Results 201 to 210 of about 78,586 (253)

Associations Between Multimorbidity, Polypharmacy and Oral Conditions in Older Adults: A Systematic Review and Meta‐Analysis

open access: yesGerodontology, Volume 43, Issue 3, Page 403-419, September 2026.
ABSTRACT Objective This systematic review and meta‐analysis evaluated the relationship between multimorbidity and polypharmacy on the oral health in older adults (aged 75 years or older). The PECO focus question set for this study was, ‘What is the occurrence, association and impact of multimorbidity and polypharmacy on the oral conditions and its ...
Kittipit Srisanoi   +5 more
wiley   +1 more source

Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights

open access: yesInternational Journal of Dermatology, Volume 65, Issue 9, Page 1828-1837, September 2026.
Summary of the microbiome‐lipid‐microinflammation axis in androgenetic alopecia (AGA). Altered sebaceous gland activity, shifts in microbial abundance on the scalp and hair follicle, and follicular microinflammation interact bidirectionally, each reinforcing the others.
Aditya K. Gupta   +3 more
wiley   +1 more source

Characterization of the Genital Microbiota in Portuguese Native Goats. [PDF]

open access: yesReprod Domest Anim
Nyoni NF   +4 more
europepmc   +1 more source

Assessment of the efficacy of large volume delayed sampling primary culture and pathogen reduction in preventing septic reactions from platelet transfusions

open access: yesTransfusion, Volume 66, Issue 9, Page 1846-1859, September 2026.
Abstract Background Many mitigation processes have been introduced to reduce septic transfusion reactions (STRs) caused by the transfusion of bacterially contaminated PLTs. Methods The efficacy of primary culture and pathogen reduction is assessed in this review using data from long‐term hemovigilance programs in the US, Canada, UK, France, Switzerland,
Michael R. Jacobs
wiley   +1 more source

Safety and efficacy of feed additives consisting of l‐lysine monohydrochloride and liquid l‐lysine produced with Corynebacterium glutamicum KCCM 80368 or KCCM 80479 for all animal species (CJ Europe GmbH)

open access: yesEFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of l‐lysine monohydrochloride and liquid l‐lysine produced with a genetically modified strain of Corynebacterium glutamicum KCCM 80368 or KCCM 80479, as nutritional and sensory additives for use in feed and water for ...
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +21 more
wiley   +1 more source

Draft genome and physiological characterization of a newly isolated L-arabinose-utilizing Corynebacterium glutamicum CS176. [PDF]

open access: yesSci Rep
Fueangbangluang P   +5 more
europepmc   +1 more source

Safety and efficacy of the feed additives consisting of l‐isoleucine ≥ 90% and l‐isoleucine ≥ 65% produced with Corynebacterium glutamicum KCCM 80388 for all animal species (CJ Europe GmbH)

open access: yesEFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of l‐isoleucine ≥ 90% and l‐isoleucine ≥ 65% produced with a genetically modified strain of Corynebacterium glutamicum (KCCM 80388), as nutritional and sensory additives for use in feed and water for drinking, for all ...
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy